ADRB2 inhibition in vitro and in vivo attenuated fibroblast proliferation, migration, activation, and ECM production under pro-fibrotic conditions (e.g., TGF-β1 or bleomycin exposure), indicating a destructive function of ADRB2 in lung fibrosis. Here, TGFB1 is linked to pulmonary fibrosis.